Zevra Therapeutics (ZVRA) Short term Debt (2014 - 2023)

Zevra Therapeutics (ZVRA) has 5 years of Short term Debt data on file, last reported at $37.7 million in Q4 2023.

• Quarterly Short term Debt changed N/A year-over-year to $37.7 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $37.7 million (changed N/A YoY) and the FY2023 annual result came in at $37.7 million, changed N/A from the prior year.
• Short term Debt improved to $37.7 million in Q4 2023, from $683000.0 in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $37.7 million in Q4 2023 to a low of $390000.0 in Q4 2020.
• A 3-year average of $12.9 million and a median of $683000.0 in 2021 frame the typical range for Short term Debt.